Ocriplasmin: A Promising New Treatment for Vitreomacular Adhesion and Associated Retinal Disorders

Ocriplasmin: A Promising New Treatment for Vitreomacular Adhesion and Associated Retinal Disorders

Vitreomacular adhesion (VMA) is an identifiable consequence of incomplete …

Expiration Date: 8/1/2013

Max Credits: 0

View Activity

Retinal Vein Occlusion: New Frontiers in Treatment

Retinal Vein Occlusion: New Frontiers in Treatment

The standard of care of retinal vein occlusion was established by 2 clinic…

Expiration Date: 8/1/2013

Max Credits: 0

View Activity

Using Antibiotics With Intravitreal Retinal Drugs

Using Antibiotics With Intravitreal Retinal Drugs

The fear of blindness is a great burden for patients and their caregivers.…

Expiration Date: 11/1/2013

Max Credits: 0

View Activity

Understanding the Pathogenesis and Diagnosis of Diabetic Macular Edema

Understanding the Pathogenesis and Diagnosis of Diabetic Macular Edema

A new paradigm has emerged for the management of diabetic macular edema (D…

Expiration Date: 4/10/2013

Max Credits: 0

View Activity

Intravitreal Steroids for Macular Disease

Intravitreal Steroids for Macular Disease

Use of intravitreal corticosteroids began in the 1970s when dexamethasone …

Expiration Date: 11/1/2013

Max Credits: 0

View Activity

Potential Treatments for DME: A Review of the Data

Potential Treatments for DME: A Review of the Data

Diabetic macular edema (DME) is the leading cause of new vision loss in wo…

Expiration Date: 4/25/2013

Max Credits: 0

View Activity

Interpreting the Science of the DRCR.net and Other Clinical Trials on the Treatment of DME

Interpreting the Science of the DRCR.net and Other Clinical Trials on the Treatment of DME

Diabetic macular edema (DME) is a major cause of decreased vision..…

Expiration Date: 4/10/2013

Max Credits: 0

View Activity

Optimizing the Use of Intravitreal Anti-VEGF Agents in the Treatment of Diabetic Macular Edema

Optimizing the Use of Intravitreal Anti-VEGF Agents in the Treatment of Diabetic Macular Edema

In recent years, there has been a paradigm shift emerging in the treatment…

Expiration Date: 4/25/2013

Max Credits: 0

View Activity

CATT and IVAN Studies

CATT and IVAN Studies

The development of agents capable of inhibiting the angiogenic signaling p…

Expiration Date: 12/1/2013

Max Credits: 0

View Activity

Early Experience Using Aflibercept in the Treatment of Wet Macular Degeneration

Early Experience Using Aflibercept in the Treatment of Wet Macular Degeneration

The approval of aflibercept by the US Food and Drug Administration in Nove…

Expiration Date: 12/1/2013

Max Credits: 0

View Activity